Live Markets
Sunday, September 13, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

CONMED Corporation (CNMD)

NYQ · Medical Devices

$46.30+0.08 (+0.17%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$1.39B
P/E (TTM)
25.03
EPS
$1.85
Div Yield
1.73%
52W Range
$31.44–$53.66
Beta
0.91

Company overview

Next earnings: 2026-11-04(53d)

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Peers in Medical Devices

All in industry →

Recent press releases

April 2026

5 months agoDEF 14AHealthcare

CONMED Corp — DEF 14A Filing

CNMDCONMED Corp

# 🧾 What This Document Is This is a **definitive proxy statement (DEF 14A)** for CONMED Corporation's 2026 Annual Meeting. It's like a detailed agenda and report card sent to shareholders before the annual meeting. It explains what will be voted on, provides company performance updates, discloses

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

CONMED Corporation has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
4,774,683 sh+2.8%
574,896 sh-42.5%
2,662,953 sh-4.8%
640,573 sh+490.6%
3,684,439 sh+2.0%
1,066,528 sh-18.1%

People at CONMED Corporation

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$138.3M
NI $6.0M
06/25
$201.6M
NI $21.4M
09/25
$337.9M
NI $2.9M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.09
Prior: $0.69
Revenue sparkline